Comments
Loading...
Attività di insider trading
Tieni traccia delle ultime attività di insider trading Arrowhead Pharma. Rimani informato sui recenti acquisti, vendite e impatto sul mercato per le azioni Arrowhead Pharma.
Cos'è l'attività interna?
L'attività di insider trading coinvolge soggetti interni all'azienda, come dirigenti, direttori e dipendenti, impegnati in transazioni sulle azioni della propria azienda. Le transazioni di acquisto e vendita degli addetti ai lavori forniscono informazioni preziose sulla loro fiducia nelle prestazioni future dell'azienda.
Cosa stanno facendo gli Arrowhead Pharmaceuticals Inc addetti ai lavori?
A Arrowhead Pharmaceuticals Inc, la recente attività interna ha attirato l'attenzione. Negli ultimi 30 giorni, gli addetti ai lavori hanno riferito di aver venduto un totale di 10.00K azioni del valore di $200.00K, nel frattempo, gli addetti ai lavori hanno segnalare nessun acquisto negli ultimi 30 giorni.
Notevoli acquisti e vendite recenti di insider
- Il giorno agosto 15, 2025, James Hamilton, l'azienda CHIEF MEDICAL OFFICER sold 10K condivisioni per $20 ciascuna.
Statistiche sulla proprietà per Arrowhead Pharmaceuticals Inc
Numero di azioni emesse
138.258M
Azioni possedute dagli insider
8.279M
Percentuale posseduta dagli Insider
6.00%
Azioni possedute dagli investitori istituzionali
60.635M
Percentuale posseduta dagli investitori istituzionali
43.9%
Aug 15, 2025 | CHIEF MEDICAL OFFICER | -10.00K | $20.00 | -$200.00K | SELL | -3.67% | 262.12K | Aug 13 - Aug 15 | ||
Apr 11, 2025 | CHIEF EXECUTIVE OFFICER | -141.12K | $10.87 | -$1.53M | SELL | -3.47% | 3.92M | Apr 09 - Apr 11 | ||
Mar 17, 2025 | CHIEF EXECUTIVE OFFICER | 288.57K | $15.07 | -$774.97K | GRANT | 7.65% | 4.06M | Mar 13 | ||
Mar 05, 2025 | CHIEF EXECUTIVE OFFICER | 0.00 | $12.67 | -$2.95M | SELL-OPTIONS | 0.00% | 3.77M | Mar 03 - Mar 04 | ||
Jan 27, 2025 | DIRECTOR | -959.00 | $21.00 | -$20.14K | SELL | -2.61% | 35.78K | Jan 23 | ||
Jan 07, 2025 | CHIEF DISCOVERY/TRANS MEDICINE | 67.27K | $19.82 | -$648.82K | GRANT | 32.84% | 272.12K | Jan 04 - Jan 06 | ||
Jan 07, 2025 | COO AND GENERAL COUNSEL | 62.82K | $19.80 | -$736.06K | GRANT | 13.53% | 527.20K | Jan 04 - Jan 07 | ||
Jan 07, 2025 | CHIEF FINANCIAL OFFICER | 54.83K | $19.77 | -$893.10K | GRANT | 13.69% | 455.43K | Jan 04 - Jan 07 | ||
Jan 06, 2025 | CHIEF EXECUTIVE OFFICER | -11.52K | $19.05 | -$219.46K | SELL | -0.31% | 3.76M | Jan 02 | ||
Dec 30, 2024 | DIRECTOR | -2.85K | $20.00 | -$57.00K | SELL | -7.20% | 36.74K | Dec 27 | ||
Dec 23, 2024 | CHIEF EXECUTIVE OFFICER | -12.56K | $19.59 | -$246.11K | SELL | -0.33% | 3.78M | Dec 23 | ||
Dec 20, 2024 | CHIEF EXECUTIVE OFFICER | 73.29K | $21.24 | -$567.49K | GRANT | 1.97% | 3.79M | Dec 18 | ||
Dec 18, 2024 | DIRECTOR | -7.50K | $21.97 | -$164.67K | SELL | -15.66% | 40.38K | Dec 16 - Dec 17 | ||
Dec 18, 2024 | DIRECTOR | -5.55K | $21.91 | -$121.56K | SELL | -4.28% | 124.17K | Dec 16 - Dec 17 | ||
Dec 18, 2024 | DIRECTOR | -8.99K | $21.91 | -$197.06K | SELL | -29.78% | 21.21K | Dec 16 | ||
Jul 03, 2024 | CHIEF COMMERCIAL OFFICER | -9.39K | $25.28 | -$237.48K | SELL | -6.88% | 127.11K | Jul 02 | ||
May 06, 2024 | DIRECTOR | -1.80K | $23.31 | -$41.93K | SELL | -5.62% | 30.20K | May 02 | ||
Apr 03, 2024 | CHIEF DISCOVERY/TRANS MEDICINE | -6.00K | $28.03 | -$168.18K | SELL | -2.85% | 204.85K | Apr 01 | ||
Mar 20, 2024 | DIRECTOR | 3.00K | $27.66 | $82.99K | BUY | 9.78% | 33.68K | Mar 18 - Mar 20 | ||
Mar 08, 2024 | CHIEF FINANCIAL OFFICER | -40.00K | $35.19 | -$1.41M | SELL | -9.08% | 400.60K | Mar 06 | ||
Feb 02, 2024 | CHIEF EXECUTIVE OFFICER | 0.00 | $23.44 | -$1.02M | SELL-OPTIONS | 0.00% | 3.72M | Jan 31 | ||
Jan 17, 2024 | CHIEF DISCOVERY/TRANS MEDICINE | -7.94K | $36.89 | -$292.90K | SELL | -3.63% | 210.85K | Jan 12 | ||
Jan 16, 2024 | DIRECTOR | -2.91K | $38.06 | -$110.79K | SELL | -2.19% | 129.71K | Jan 11 | ||
Jan 16, 2024 | DIRECTOR | -3.93K | $38.07 | -$149.76K | SELL | -7.59% | 47.87K | Jan 11 | ||
Jan 16, 2024 | DIRECTOR | -3.15K | $38.06 | -$119.79K | SELL | -4.92% | 60.78K | Jan 11 | ||
Jan 16, 2024 | DIRECTOR | -4.72K | $38.10 | -$179.81K | SELL | -12.85% | 32.00K | Jan 11 | ||
Jan 08, 2024 | CHIEF COMMERCIAL OFFICER | 74.93K | $33.89 | -$2.51K | GRANT | 121.68% | 136.50K | Jan 04 - Jan 05 | ||
Jan 08, 2024 | CHIEF FINANCIAL OFFICER | 58.90K | $35.27 | -$567.91K | GRANT | 15.43% | 440.60K | Jan 04 - Jan 05 | ||
Jan 08, 2024 | CHIEF MEDICAL OFFICER | 66.70K | $35.26 | -$292.80K | GRANT | 50.60% | 198.50K | Jan 04 - Jan 05 | ||
Jan 05, 2024 | — | 36.56K | $34.69 | -$1.33M | GRANT | 20.06% | 218.79K | Jan 03 - Jan 05 | ||
Jan 05, 2024 | COO AND GENERAL COUNSEL | 51.81K | $34.36 | -$1.14M | GRANT | 12.56% | 464.38K | Jan 03 - Jan 05 | ||
Jan 04, 2024 | CHIEF EXECUTIVE OFFICER | -9.95K | $31.01 | -$308.64K | SELL | -0.27% | 3.72M | Jan 02 | ||
Dec 22, 2023 | CHIEF EXECUTIVE OFFICER | -12.00K | $28.54 | -$342.48K | SELL | -0.32% | 3.73M | Dec 20 | ||
Nov 22, 2023 | CHIEF MEDICAL OFFICER | -19.70K | $28.80 | -$567.32K | SELL | -13.00% | 131.80K | Nov 20 | ||
Oct 27, 2023 | CHIEF EXECUTIVE OFFICER | -24.34K | $24.21 | -$589.22K | SELL | -0.65% | 3.74M | Oct 25 | ||
Oct 02, 2023 | DIRECTOR | -1.55K | $26.33 | -$40.81K | SELL | -6.66% | 21.73K | Sep 28 | ||
Sep 20, 2023 | CHIEF EXECUTIVE OFFICER | 0.00 | $16.44 | -$1.35M | SELL-OPTIONS | 0.00% | 3.76M | Sep 18 | ||
Jul 06, 2023 | CHIEF COMMERCIAL OFFICER | -8.93K | $35.31 | -$315.14K | SELL | -12.66% | 61.58K | Jul 03 | ||
Jul 05, 2023 | — | -3.00K | $35.53 | -$106.59K | SELL | -1.57% | 188.48K | Jun 30 | ||
Jun 29, 2023 | CHIEF FINANCIAL OFFICER | -15.00K | $36.20 | -$543.00K | SELL | -3.78% | 381.70K | Jun 27 | ||
May 08, 2023 | DIRECTOR | -6.50K | $40.90 | -$265.85K | SELL | -4.76% | 130.13K | May 05 | ||
May 05, 2023 | CHIEF EXECUTIVE OFFICER | 0.00 | $20.66 | -$3.91M | SELL-OPTIONS | 0.00% | 3.76M | May 03 - May 04 | ||
Mar 06, 2023 | DIRECTOR | -11.35K | $32.65 | -$370.58K | SELL | -59.06% | 7.87K | Mar 03 | ||
Mar 01, 2023 | DIRECTOR | -875.00 | $32.62 | -$28.54K | SELL | -3.32% | 25.50K | Feb 27 | ||
Jan 11, 2023 | DIRECTOR | 4.67K | $30.00 | -$96.00K | GRANT | 14.52% | 36.82K | Jan 09 - Jan 10 | ||
Jan 06, 2023 | COO AND GENERAL COUNSEL | -15.00K | $37.39 | -$560.85K | SELL | -3.50% | 413.38K | Jan 05 | ||
Jan 06, 2023 | — | -13.80K | $37.40 | -$516.23K | SELL | -6.72% | 191.48K | Jan 05 | ||
Jan 05, 2023 | COO AND GENERAL COUNSEL | 47.50K | $38.33 | -$670.80K | GRANT | 12.47% | 428.38K | Jan 03 - Jan 04 | ||
Jan 05, 2023 | — | 49.66K | $38.38 | -$396.74K | GRANT | 31.91% | 205.29K | Jan 03 - Jan 04 | ||
Dec 30, 2022 | CHIEF FINANCIAL OFFICER | -30.63K | $40.00 | -$1.23M | SELL | -8.34% | 336.70K | Dec 29 | ||
Nov 22, 2022 | CHIEF MEDICAL OFFICER | -19.50K | $29.99 | -$584.74K | SELL | -17.57% | 91.50K | Nov 21 | ||
Feb 14, 2022 | CHIEF EXECUTIVE OFFICER | 0.00 | $28.55 | -$6.84M | SELL-OPTIONS | 0.00% | 4.06M | Feb 11 | ||
Jan 07, 2022 | GENERAL COUNSEL | -33.30K | $61.72 | -$2.01M | SELL | -8.73% | 348.07K | Dec 04 - Jan 05 | ||
Jan 06, 2022 | CHIEF FINANCIAL OFFICER | -40.00K | $61.70 | -$2.47M | SELL | -7.94% | 464.00K | Jan 05 | ||
Jan 06, 2022 | — | -25.63K | $64.57 | -$1.65M | SELL | -14.14% | 155.63K | Jan 04 - Jan 05 | ||
Jan 04, 2022 | DIRECTOR | -4.50K | $64.72 | -$291.24K | SELL | -14.88% | 25.75K | Jan 03 | ||
Jan 04, 2022 | DIRECTOR | -4.05K | $64.75 | -$262.23K | SELL | -45.00% | 4.95K | Jan 03 | ||
Jan 04, 2022 | DIRECTOR | -4.50K | $64.71 | -$291.18K | SELL | -20.93% | 17.00K | Jan 03 | ||
Jan 04, 2022 | DIRECTOR | -4.50K | $64.71 | -$291.19K | SELL | -5.00% | 85.50K | Jan 03 | ||
Dec 29, 2021 | DIRECTOR | 0.00 | $66.37 | $43.47K | GRANT | 0.00% | 122.37K | Dec 28 | ||
Dec 29, 2021 | DIRECTOR | -3.40K | $66.82 | -$227.19K | SELL | -8.51% | 36.57K | Dec 28 | ||
Dec 17, 2021 | CHIEF EXECUTIVE OFFICER | -60.00K | $67.56 | -$4.05M | SELL | -1.83% | 3.22M | Dec 15 | ||
Nov 22, 2021 | CHIEF MEDICAL OFFICER | -19.50K | $69.31 | -$1.35M | SELL | -14.94% | 111.00K | Nov 19 | ||
Oct 22, 2021 | CHIEF EXECUTIVE OFFICER | -65.00K | $65.77 | -$4.27M | SELL | -1.94% | 3.28M | Oct 20 - Oct 22 | ||
Sep 14, 2021 | DIRECTOR | -5.00K | $63.76 | -$318.80K | SELL | -35.71% | 9.00K | Sep 13 | ||
Sep 10, 2021 | DIRECTOR | -5.00K | $65.24 | -$326.20K | SELL | -3.93% | 122.37K | Sep 09 | ||
Jun 25, 2021 | DIRECTOR | -5.00K | $89.85 | -$449.25K | SELL | -18.87% | 21.50K | Jun 24 | ||
Jun 24, 2021 | CHIEF COMMERCIAL OFFICER | -3.63K | $89.22 | -$323.42K | SELL | -3.31% | 105.75K | Jun 22 | ||
Jun 24, 2021 | DIRECTOR | -4.50K | $89.21 | -$401.44K | SELL | -3.41% | 127.37K | Jun 22 | ||
Feb 24, 2021 | DIRECTOR | -1.13K | $88.73 | -$99.82K | SELL | -4.09% | 26.38K | Feb 22 | ||
Feb 10, 2021 | GENERAL COUNSEL | 0.00 | $46.84 | -$7.49M | SELL-OPTIONS | 0.00% | 293.38K | Feb 08 | ||
Jan 19, 2021 | DIRECTOR | -3.00K | $83.28 | -$249.84K | SELL | -9.84% | 27.50K | Jan 15 | ||
Jan 15, 2021 | — | -10.00K | $81.29 | -$812.94K | SELL | -7.34% | 126.25K | Jan 14 | ||
Jan 12, 2021 | CHIEF FINANCIAL OFFICER | -13.04K | $81.02 | -$1.06M | SELL | -2.85% | 444.00K | Jan 11 - Jan 12 | ||
Jan 08, 2021 | CHIEF COMMERCIAL OFFICER | -15.63K | $75.00 | -$1.17M | SELL | -12.50% | 109.38K | Jan 07 | ||
Jan 07, 2021 | GENERAL COUNSEL | -25.00K | $72.41 | -$1.81M | SELL | -7.85% | 293.38K | Jan 06 | ||
Jan 07, 2021 | CHIEF FINANCIAL OFFICER | -30.63K | $72.44 | -$2.22M | SELL | -6.28% | 457.04K | Jan 06 | ||
Jan 07, 2021 | — | -38.75K | $72.51 | -$2.81M | SELL | -22.14% | 136.25K | Jan 05 - Jan 06 | ||
Jan 05, 2021 | DIRECTOR | 5.00K | $76.09 | -$304.36K | GRANT | 5.88% | 90.00K | Jan 01 - Jan 04 | ||
Jan 05, 2021 | DIRECTOR | 5.50K | $76.08 | -$304.32K | GRANT | 4.83% | 119.37K | Jan 01 - Jan 04 | ||
Jan 05, 2021 | DIRECTOR | 5.25K | $76.08 | -$285.30K | GRANT | 21.00% | 30.25K | Jan 01 - Jan 04 | ||
Dec 18, 2020 | — | -9.57K | $79.32 | -$759.44K | GIFT | -38.96% | 15.00K | Dec 07 - Dec 17 | ||
Dec 11, 2020 | — | -3.00K | $71.26 | -$213.78K | SELL | -10.71% | 25.00K | Dec 10 | ||
Dec 10, 2020 | — | 0.00 | $35.37 | -$3.67M | OPTION EXERCISE | 0.00% | 2.51M | Dec 08 - Dec 09 | ||
Nov 23, 2020 | — | -31.25K | $69.06 | -$2.16M | SELL | -100.00% | 0.00 | Nov 19 - Nov 20 | ||
Nov 20, 2020 | — | -19.50K | $69.39 | -$1.35M | SELL | -13.00% | 130.50K | Nov 19 | ||
Nov 12, 2020 | — | 0.00 | $41.96 | -$2.39M | OPTION EXERCISE | 0.00% | 427.67K | Nov 09 | ||
Oct 26, 2020 | — | 1.00K | $50.47 | $50.47K | PURCHASE | 6.06% | 17.50K | Oct 08 | ||
Oct 23, 2020 | — | -100.00K | $58.21 | -$5.82M | SELL | -3.84% | 2.51M | Oct 23 | ||
Oct 22, 2020 | — | 0.00 | $30.09 | -$1.40M | OPTION EXERCISE | 0.00% | 427.67K | Oct 20 | ||
Oct 13, 2020 | — | -10.00K | $48.00 | -$480.00K | SELL | -24.41% | 30.97K | Oct 09 |
FAQ
L'insider trading è legale?
L'insider trading è legale a condizione che gli insider segnalino le loro operazioni alla SEC. Il trading illegale di titoli si verifica quando l'insider viola un dovere fiduciario o non segnala le sue operazioni.
Quali sono alcuni esempi di manipolazione del mercato?
L'insider trading, gli schemi di pump and dump, il front running e i wash trade sono tutti esempi di manipolazione del mercato. Gli investitori che seguono i movimenti delle attività degli insider dovrebbero riflettere attentamente sul motivo per cui questi insider stanno negoziando le loro azioni prima di procedere.
Sfoglia insider trading su tutte le azioni.